Code intelligence

Z94.0 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code Z94.0.

Critical code riskView ICD-10 detail

Signal breakdown

15 shown · 15 total in platform

Risk: Critical

Critical

High

73%

Routine

13%

Low

New this month

—

alerts added in last 30 days

Effective soon

—

no upcoming deadlines

Federal Register Proposed Rule: Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, Conditions for Coverage for End-Stage Renal Disease Facilities, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model

Policy FR-2024-14359 · ESRD

Critical

Changes to ESRD payment rates and quality requirements proposed.

View alert

LCD L38582: MolDX: Molecular Testing for Solid Organ Allograft Rejection — CGS

Policy LCD-L38582 · Transplantation

High

New molecular testing coverage impacts organ transplant billing.

View alert

LCD L34062: Dialysis Access Maintenance — CGS

Policy LCD-L34062 · ESRD

High

New dialysis maintenance guidelines effective 01/22/2026.

View alert

LCD L38629: MolDX: Molecular Testing for Solid Organ Allograft Rejection — Noridian

Policy LCD-L38629 · Multi-specialty

High

New LCD impacts molecular testing billing practices.

View alert

LCD L38671: MolDX: Molecular Testing for Solid Organ Allograft Rejection — Noridian

Policy LCD-L38671 · Transplantation

High

New LCD for organ rejection testing impacts billing compliance.

View alert

Proposed LCD DL40140: MolDX: Molecular Testing for Solid Organ Allograft Rejection — CGS

Policy LCD-DL40140 · Clinical Laboratory

High

Impact of new LCD on organ transplant testing reimbursement.

View alert

LCD L38568: MolDX: Molecular Testing for Solid Organ Allograft Rejection — Palmetto GBA

Policy LCD-L38568 · Multi-specialty

High

New LCD for molecular testing impacts billing practices.

View alert

Proposed LCD DL40060: MolDX: Molecular Testing for Solid Organ Allograft Rejection — Noridian

Policy LCD-DL40060 · Nephrology

High

New LCD could reshape billing for organ transplant tests.

View alert

Proposed LCD DL40249: MolDX: Molecular Testing for Solid Organ Allograft Rejection — WPS

Policy LCD-DL40249 · Transplantation

High

New LCD could impact solid organ testing reimbursements.

View alert

Proposed LCD DL40062: MolDX: Molecular Testing for Solid Organ Allograft Rejection — Noridian

Policy LCD-DL40062 · Multi-specialty

High

Impact of LCD on organ transplant testing reimbursements.

View alert

LCD L40140: MolDX: Molecular Testing for Solid Organ Allograft Rejection — CGS

Policy LCD-L40140 · Clinical Laboratory

High

CGS finalizes molecular allograft rejection testing coverage for KY & OH.

View alert

Proposed LCD DL40058: MolDX: Molecular Testing for Solid Organ Allograft Rejection — Palmetto GBA

Policy LCD-DL40058 · Clinical Laboratory

High

New LCD may change billing for organ transplant tests.

View alert

LCD L40060: MolDX: Molecular Testing for Solid Organ Allograft Rejection — Noridian

Policy LCD-L40060 · Clinical Laboratory

Routine

Noridian finalizes molecular allograft rejection testing coverage (eff. 8/30/26)

View alert

LCD L40062: MolDX: Molecular Testing for Solid Organ Allograft Rejection — Noridian

Policy LCD-L40062 · Clinical Laboratory

Routine

Noridian finalizes coverage for molecular allograft rejection testing, eff. 8/30

View alert

LCD L33824: Immunosuppressive Drugs — DME MAC

Policy LCD-L33824 · DME

Low

DME MAC LCD for immunosuppressive drugs effective Jan 1, 2026.

View alert

Audit documentation

Building an audit file that includes Z94.0?

The Tripwire Audit Pack exports 12 months of ESRD policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the ESRD audit pack — $349One-time purchase · not a subscription